Novel 3,3-diphenylpropylamines of the formula ##STR00001## and stereoisomers and physiologically acceptable acid addition salt thereof; wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are as defined herein; methods of use thereof; and pharmaceutical compositions thereof.